Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
08/16/1990 | DE4003975A1 Antibiotic cyclic polypeptide, janthinomycin - active against Gram-positive and Gram-negative bacteria and anaerobic bacteria |
08/16/1990 | DE4003844A1 Neue cyclosporin enthaltende galenische formulierungen New cyclosporin-containing pharmaceutical formulations |
08/16/1990 | DE3904580A1 Thrombolytic agent |
08/16/1990 | CA2009982A1 Phosphorus containing renin inhibitors |
08/15/1990 | CN1044660A Biologically active whey protein composition, mtehod for producing it and use of composition |
08/15/1990 | CN1044659A Whey protein composition, method for producing it and application of whey protein composition |
08/15/1990 | CA2323630A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections |
08/15/1990 | CA2008703A1 Method of reducing pre-and post-ischemic myocardial arrhythmias and fibrillation |
08/14/1990 | WO1990009438A1 Novel thrombolytic |
08/14/1990 | USRE33300 Leukotriene antagonists; antiallergens |
08/14/1990 | US4948913 Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues |
08/14/1990 | US4948877 Preparation of retrovirus-free immunoglobulins |
08/14/1990 | US4948875 Novel polypeptide having an anti-tumor activity and a method of preparation thereof |
08/14/1990 | US4948873 Gonadoliberine analogues of high activity |
08/14/1990 | US4948791 Novel Cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum |
08/14/1990 | CA1272850A1 Muramylpeptide active ester derivatives |
08/14/1990 | CA1272849A1 Dipeptides of l-5-hydroxytryptophan, processes for their preparation and drugs in which they are present |
08/13/1990 | CA2009918A1 Nucleic acid encoding sodium channel protein |
08/10/1990 | CA2009709A1 Derivatives of 3-pyroglutamyl-thiazolidine-4-carboxylic acid and their pharmacological properties |
08/09/1990 | WO1990009396A1 Peptide and adsorbent comprising same immobilized on carrier |
08/09/1990 | WO1990008958A1 Excretory/secretory antigens of tapeworm (cysticercus cellulosae) for use in immunodiagnosis and vaccine preparation |
08/09/1990 | WO1990008833A1 Expression of recombinant fibronectin in genetically engineered cells |
08/09/1990 | WO1990008824A1 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
08/09/1990 | WO1990008823A1 Somatotropin analogs |
08/09/1990 | WO1990008822A1 Erythropoietin receptor |
08/09/1990 | WO1990008781A1 Tenascin-induced cell attachment and the tenascin receptor |
08/09/1990 | WO1990008780A1 Method for detecting inhibitors of tat protein |
08/09/1990 | WO1990008778A1 Human derived monocyte attracting purified peptide products useful in a method of treating infection and neoplasms in a human body |
08/09/1990 | WO1990008777A1 HUMAN DERIVED MONOCYTE ATTRACTING PURIFIED PROTEIN PRODUCT USEFUL IN A METHOD OF TREATING INFECTION AND NEOPLASM IN HUMAN BODY, AND THE CLONING OF FULL LENGTH cDNA THEREOF |
08/09/1990 | WO1990008772A1 Processes for producing polypeptide inhibitors of platelet activation and methods, combinations and compositions using them |
08/09/1990 | WO1990008771A1 Dna encoding a growth factor specific for epithelial cells |
08/09/1990 | WO1990008583A2 Thyroleberin as immunomodulator and lipid regulator |
08/09/1990 | WO1990008557A1 Pharmaceutical formulations of plasminogen activator proteins |
08/09/1990 | WO1990008556A1 Compositions and method for the treatment or prophylaxis of sepsis or septic shock |
08/09/1990 | WO1990008555A1 Composition and method for treating benign prostatic hypertrophy |
08/09/1990 | WO1990008554A1 Treatment of leukocyte dysfunction with gm-csf |
08/09/1990 | WO1990008553A1 Transdermal drug delivery composition |
08/09/1990 | WO1990008552A1 Composition and treatment with peptide combinations |
08/09/1990 | WO1990008551A1 Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle |
08/09/1990 | WO1990008540A1 Treatment of disease associated with hiv-infections |
08/09/1990 | WO1990006953A3 Method for preparing water soluble polypeptides |
08/09/1990 | WO1990006943A3 Novel tnf peptides |
08/09/1990 | CA2026881A1 Peptide and adsorbent thereof immobilized on carrier |
08/09/1990 | CA2009618A1 New adamantyl comprising tripeptides, derivatives and hydrochlorides thereof, their preparation and use |
08/09/1990 | CA2009613A1 Polypeptide synthesis |
08/09/1990 | CA2007895A1 Janthinocin |
08/08/1990 | WO1990009437A1 Tissue plasminogene activator derivative |
08/08/1990 | EP0381640A1 New thrombolytic compositions |
08/08/1990 | EP0381584A2 Use of certain gamma-interferons in the treatment of ovary cancer |
08/08/1990 | EP0381514A2 Use of N-methyl-sphingosine as inhibitor of cell growth |
08/08/1990 | EP0381490A2 Gene therapy using stromal cells |
08/08/1990 | EP0381427A2 Vaccine Composition |
08/08/1990 | EP0381345A1 Aqueous liquid desmopressin-CMC pharmaceutical composition |
08/08/1990 | EP0381340A2 Peptides with sulphate ester groups |
08/08/1990 | EP0381331A2 Gene sequences encoding modified residues situated in the protease domain of tpa |
08/08/1990 | EP0381310A1 Monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosides and method for production thereof |
08/08/1990 | EP0381146A1 Antigenic noninfectious HIV-producing cloned T cell |
08/08/1990 | EP0381075A2 Method for treating addiction to a drug of abuse employing an ace inhibitor |
08/08/1990 | EP0381074A2 Method for facilitating dieting employing an ACE inhibitor |
08/08/1990 | EP0380805A1 Renin inhibitors containing C-terminal dihydroxy amides |
08/08/1990 | EP0380656A1 Defective hepadnaviruses and producer cell line for vaccines and treatment of liver diseases and disorders |
08/08/1990 | EP0380546A1 Polypeptides with type iv collagen activity. |
08/08/1990 | EP0243390B1 New mammal protein having an immunomodulating and progestational activity |
08/08/1990 | EP0191061B1 Polypeptide and polypeptide composition |
08/08/1990 | EP0165123B1 Lipophile derivatives of muramyl peptides having macrophage-activating properties, compositions containing them and processes for obtaining them |
08/08/1990 | CN1009055B Monoclonal antibody to a human carcinoma tumor associated antigen |
08/08/1990 | CA2009511A1 Antiproliferation factor |
08/07/1990 | USH810 Morphine agonist |
08/07/1990 | US4946944 Process for the selective extraction of metalloproteins from whey by adsorption and elution |
08/07/1990 | US4946943 Purification of ribotoxins and their conjugates |
08/07/1990 | US4946941 Novel glycopeptide antibiotics |
08/07/1990 | US4946828 Terminal carboxyl group of b-chain blocked with amide; neutral amino acid substitutes; positive charge |
08/07/1990 | US4946788 Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications |
08/07/1990 | US4946785 Method of suppressing the thermal degradation of urokinase |
08/07/1990 | US4946677 Preparations active against pseudomonas aeruginosa infections and methods of producing them |
08/07/1990 | US4946675 Hepatic blocking agents |
08/07/1990 | US4946674 Gamma interferons |
08/07/1990 | CA2045620A1 Method for detecting inhibitors of tat protein |
08/07/1990 | CA2009390A1 Viper venom polypeptides and variants |
08/02/1990 | DE4001087A1 Verwendung von (alpha)-aminofluoroketonen zur behandlung von cardiovaskulaeren stoerungen und erhoehtem blutdruck Use of (alpha) -aminofluoroketonen for treatment of cardiovaskulaeren disorders and an elevated blood pressure |
08/02/1990 | CA2009106A1 Use of some gamma-interferons for the preparation of pharmaceutical compositions for the intraperitoneal treatment of the cancer of the ovary |
08/02/1990 | CA2009071A1 Delivery of cytotoxic agents |
08/01/1990 | WO1990008819A1 Vaccine for the preventative treatment of infection of liver fluke in ruminants |
08/01/1990 | EP0380443A2 Monoclonal antibodies specific for thrombin hirudin |
08/01/1990 | EP0380422A1 Process to prepare proteins inhibiting lymphocytotoxicity and the complement, and proteins obtained thereby |
08/01/1990 | EP0380370A2 Inhibiting tumour recurrence after surgical resection |
08/01/1990 | EP0380334A2 Urokinase precursor-lipid composite |
08/01/1990 | EP0380230A2 Immunogenic compositions against gastrin peptides |
08/01/1990 | EP0380084A2 Method for the inhibition of cell-cell and cell substratum interactions by the blocking of carbohydrate-carbohydrate interactions |
08/01/1990 | EP0380018A2 Rat monoclonal antibodies directed against human antigens and processes for preparation thereof |
08/01/1990 | EP0379904A1 A soluble molecule related to but distinct from ICAM-1 |
08/01/1990 | EP0379890A1 New tissue plasminogen activator |
08/01/1990 | EP0379708A1 Fungi strain Tolypocladiam varium and process for obtaining complexes of antibiotic cyclosporin and/or its components |
08/01/1990 | EP0379534A1 Method of purifying cross-linked hemoglobin |
08/01/1990 | EP0379511A1 Polypeptides with laminin activity. |
08/01/1990 | EP0379506A1 Recombinant plasmids for producing human adrenocorticotropic hormone (acth) |
08/01/1990 | CA2045663A1 Vaccine for the preventative treatment of infection of liver fluke in ruminants |
08/01/1990 | CA2045578A1 Anaphylatoxin-receptor ligands |
08/01/1990 | CA2009012A1 Method for the diagnosis of virulent bacteria |
08/01/1990 | CA2008808A1 Vaccine composition |